Rapid Responses to:

NEWS EXTRA: Ray Moynihan Global consulting firm calls for revolution in drug marketing BMJ 2003; 327: 468-d [Full text]

Rapid Responses: Submit a response to this article

Rapid Responses published:

Drug marketing deserves recognition

Peter R Mansfield   (29 August 2003)

Drug marketing deserves recognition 29 August 2003
Peter R Mansfield, Director Healthy Skepticism, 34 Methodist St, Willunga SA 5172, Australia Send response to journal: Re: Drug marketing deserves recognition	Ray Moynihan deserves congratulations for yet another excellent contribution to the literature on drug marketing. This literature is hard to find on Medline because the nearest MeSH terms: “Advertising” and “Drug Industry” have been applied with low sensitivity and low specificity for drug marketing. Many of the best articles this year have been published in the BMJ. They have been classified by the BMJ into the “Regulation” or “Other Ethics” collections but deserve a collection of their own. Following the marvellous May 31, 2003 edition is it not time for the BMJ to create a separate collection for Marketing in general and/or a collection for Drug Marketing in particular? Competing interests:   I am the Director of Healthy Skepticism. Our main aim is to improve health by reducing harm from misleading drug promotion.